The Global Immunoprotein Diagnostic Testing Market is expected to grow by $ 5.56 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period

NEXT STORY
Ziopharm Comments on Institutional Shareholder Services’ Recommendation to Reject WaterMill’s Attempt to Remove Half of Ziopharm’s Board of Directors
PREV STORY
The Asia Pacific RNAi therapeutics market is expected to reach US$ 218.64 million by 2027 from US$ 107.63 million in 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Intra-Cellular Therapies Continues to Strengthen Its Commercial Leadership Team; John A. Bardi Appointed as Senior Vice President, Market Access, Policy and Government Affairs

author_avatar
NASDAQ Market News

Ziopharm Oncology Third Quarter 2018 Financial Results Conference Call Rescheduled to Nov. 12

BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP), today announced that ...

author_avatar
NASDAQ Market News

CBT Pharmaceuticals and Zhejiang Bossan Pharmaceutical Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments

CBT’s c-Met inhibitor and anti-PD1 antibody to be evaluated in combination with Bossan’s EGFR inhibitorPLEASANTON, ...

author_avatar
NASDAQ Market News